InsidersTradesSigma
Track the 迈普医学 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 迈普医学 has published 6 reports. Market capitalisation: €4.2bn. The latest transaction was filed on 22 May 2024 (Purchase). Among the most active insiders: 袁美福. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€147,359
4 ops.
Buy Volume
€1m
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,050 of 28,753 companies
64.3
score / 100
Value39
Quality89
FCF yld2.8%
Earn yld2.7%
EV/EBITDA27.0x
ROE14%
Gross mgn80%
Net mgn31%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 May 2024
Declarations6 total
6 of 6 declarations
About 迈普医学
迈普医学 is a company specializing in the healthcare and pharmaceutical sector, providing innovative solutions for diagnosis and treatment. It is listed on the XSHE market.